These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 21069535

  • 1. Implantable cardioverter defibrillator and 50-Hz electric and magnetic fields exposure in the workplace.
    Souques M, Magne I, Lambrozo J.
    Int Arch Occup Environ Health; 2011 Jan; 84(1):1-6. PubMed ID: 21069535
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of the safety of users of active implantable medical devices (AIMD) in the working environment in terms of exposure to electromagnetic fields - Practical approach to the requirements of European Directive 2013/35/EU.
    Zradziński P, Karpowicz J, Gryz K, Leszko W.
    Int J Occup Med Environ Health; 2018 Dec 20; 31(6):795-808. PubMed ID: 30520435
    [Abstract] [Full Text] [Related]

  • 3. Electromagnetic interference from welding and motors on implantable cardioverter-defibrillators as tested in the electrically hostile work site.
    Fetter JG, Benditt DG, Stanton MS.
    J Am Coll Cardiol; 1996 Aug 20; 28(2):423-7. PubMed ID: 8800120
    [Abstract] [Full Text] [Related]

  • 4. Electromagnetic interference with implantable cardioverter-defibrillators at power frequency: an in vivo study.
    Napp A, Joosten S, Stunder D, Knackstedt C, Zink M, Bellmann B, Marx N, Schauerte P, Silny J.
    Circulation; 2014 Jan 28; 129(4):441-50. PubMed ID: 24163067
    [Abstract] [Full Text] [Related]

  • 5. Electromagnetic interference with cardiac pacemakers and implantable cardioverter-defibrillators from low-frequency electromagnetic fields in vivo.
    Tiikkaja M, Aro AL, Alanko T, Lindholm H, Sistonen H, Hartikainen JE, Toivonen L, Juutilainen J, Hietanen M.
    Europace; 2013 Mar 28; 15(3):388-94. PubMed ID: 23125355
    [Abstract] [Full Text] [Related]

  • 6. Exposure to 50-Hz electric field and incidence of leukemia, brain tumors, and other cancers among French electric utility workers.
    Guénel P, Nicolau J, Imbernon E, Chevalier A, Goldberg M.
    Am J Epidemiol; 1996 Dec 15; 144(12):1107-21. PubMed ID: 8956623
    [Abstract] [Full Text] [Related]

  • 7. Workers with Cardiac AIMD Exposed to EMF: Methods and Case Studies for Risk Analysis in the Framework of the European Regulations.
    Mattei E, Censi F, Calcagnini G, Falsaperla R.
    Int J Environ Res Public Health; 2021 Sep 15; 18(18):. PubMed ID: 34574648
    [Abstract] [Full Text] [Related]

  • 8. Interference thresholds for active implantable cardiovascular devices in occupational low-frequency electric and magnetic fields: a numerical and in vitro study.
    Zhou M, Kourtiche D, Claudel J, Deschamps F, Magne I, Roth P, Schmitt P, Souques M, Nadi M.
    Med Eng Phys; 2022 Jun 15; 104():103799. PubMed ID: 35641069
    [Abstract] [Full Text] [Related]

  • 9. Implantable cardioverter defibrillators in electric and magnetic fields of 400 kV power lines.
    Korpinen L, Kuisti H, Elovaara J, Virtanen V.
    Pacing Clin Electrophysiol; 2014 Mar 15; 37(3):297-303. PubMed ID: 24033389
    [Abstract] [Full Text] [Related]

  • 10. Are patients with cardiac implants protected against electromagnetic interference in daily life and occupational environment?
    Napp A, Stunder D, Maytin M, Kraus T, Marx N, Driessen S.
    Eur Heart J; 2015 Jul 21; 36(28):1798-804. PubMed ID: 25908772
    [Abstract] [Full Text] [Related]

  • 11. The revised electromagnetic fields directive and worker exposure in environments with high magnetic flux densities.
    Stam R.
    Ann Occup Hyg; 2014 Jun 21; 58(5):529-41. PubMed ID: 24557933
    [Abstract] [Full Text] [Related]

  • 12. Electromagnetic interference in implantable cardioverter defibrillators: present but rare.
    von Olshausen G, Rondak IC, Lennerz C, Semmler V, Grebmer C, Reents T, Ammar-Busch S, Buiatti A, Bourier F, Deisenhofer I, Kolb C.
    Clin Res Cardiol; 2016 Aug 21; 105(8):657-665. PubMed ID: 26825328
    [Abstract] [Full Text] [Related]

  • 13. Electromagnetic interference from left ventricular assist devices in patients with subcutaneous implantable cardioverter-defibrillators.
    Ishida Y, Payne JE, Field ME, Gold MR.
    J Cardiovasc Electrophysiol; 2020 May 21; 31(5):1195-1201. PubMed ID: 32128931
    [Abstract] [Full Text] [Related]

  • 14. Interaction between electronic article surveillance systems and implantable defibrillators: insights from a fourth generation ICD.
    Mathew P, Lewis C, Neglia J, Krol RB, Saksena S.
    Pacing Clin Electrophysiol; 1997 Nov 21; 20(11):2857-9. PubMed ID: 9392818
    [Abstract] [Full Text] [Related]

  • 15. [Exposure to electromagnetic fields with frequencies of 50 Hz and changes in the circulatory system in workers at electrical power stations].
    Bortkiewicz A, Zmyślony M, Gadzicka E.
    Med Pr; 1998 Nov 21; 49(3):261-74. PubMed ID: 9760436
    [Abstract] [Full Text] [Related]

  • 16. Electromagnetic force from electric vehicles: Potential electromagnetic interference source for subcutaneous implantable defibrillator.
    Salih A, Salam K, Goswami T, Wase A.
    Pacing Clin Electrophysiol; 2024 Jul 21; 47(7):885-892. PubMed ID: 38830796
    [Abstract] [Full Text] [Related]

  • 17. Electromagnetic interference of dental equipment with implantable cardioverter defibrillators.
    Dadalti MTS, da Cunha AJLA, Araújo MCP, Moraes LGB, Risso PA.
    Acta Odontol Scand; 2017 Nov 21; 75(8):584-587. PubMed ID: 28799814
    [Abstract] [Full Text] [Related]

  • 18. [Analysis on outer hair cells hazards from occupational exposure to low frequency electric and magnetic fields and magnetic fields and its related factors].
    Zhao J, Sun J, Jia Z, Diao M, Liu Y, Tian F.
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Nov 21; 27(22):1247-51. PubMed ID: 24616982
    [Abstract] [Full Text] [Related]

  • 19. Absenteeism and mortality of workers exposed to electromagnetic fields in the French Electricity Company.
    Chevalier A, Souques M, Coing F, Dab W, Lambrozo J.
    Occup Med (Lond); 1999 Nov 21; 49(8):517-24. PubMed ID: 10658304
    [Abstract] [Full Text] [Related]

  • 20. [Assessment of the risk due to exposure to EMF with particular reference to the protection of sensitive subjects].
    Falsaperla R, Mattei E, Censi F, Bogi A, Pinto I, Calcagnini G.
    G Ital Med Lav Ergon; 2019 Dec 21; 41(4):280-284. PubMed ID: 32126594
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.